Home / Inspections / 1152917

FDA Inspection 1152917 — Xytex Laboratories

Xytex Laboratories — FEI 3003420280

The FDA completed an inspection of Xytex Laboratories on September 2, 2021 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 2, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Atlanta, GA (United States)

Facility

Other inspections at this facility

  • 1245336 (NAI Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1069228 (NAI Fri Sep 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 986675 (NAI Thu Jan 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 949253 (NAI Mon Nov 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 712184 (NAI Mon Mar 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources